Citadel Advisors’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-230,600
Closed -$5.95M 9157
2019
Q1
$5.95M Buy
+230,600
New +$6.38M ﹤0.01% 2754
2017
Q3
Sell
-9,700
Closed -$201K 7513
2017
Q2
$201K Sell
9,700
-15,600
-62% -$322K ﹤0.01% 6561
2017
Q1
$515K Buy
+25,300
New +$532K ﹤0.01% 4970

Other funds holding BAK

Citadel Advisors's BAK Position: Q2 2026 in Review

Citadel Advisors opened a new position in Braskem (BAK) in Q2 2026: 36,678 shares worth $89.5K. The stake represents ﹤0.01% of the portfolio and ranks #12771 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in BAK as recently as Q4 2025.

Citadel Advisors first reported a position in BAK in Q2 2014 and has held it in 28 quarters since. The position peaked at $6.98M in Q2 2017. 63 funds tracked by Wall St. Rank hold BAK as of Q2 2026.

  • Citadel Advisors held 36,678 shares of Braskem worth $89.5K as of Q2 2026.
  • Braskem was a new Citadel Advisors position in Q2 2026.
  • Braskem made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12771 holding.
  • Citadel Advisors first reported a position in Braskem in Q2 2014 and has held it in 28 quarters since.
  • Citadel Advisors's Braskem position peaked at $6.98M in Q2 2017.
  • 63 funds tracked by Wall St. Rank held Braskem as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.